# US 12,758,606 B2 · Food supplement to promote body weight loss

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 12,758,606 B2
- Document ID: US12758606B2
- Status: Granted
- Kind: B2
- Application number: 18/280,508
- Filed: 2022-03-08
- Published: 2024-05-09
- Granted: 2026-10-13
- Earliest claimed: 2021-03-09
- Assignees: NGN Healthcare-New Generation Nutraceuticals S.R.L.
- Applicants: Ngn Healthcare—New Generation Nutraceuticals S.R.L.
- Inventors: Ettore Novellino; Gian Carlo Tenore
- Web page: https://patentgrep.com/patent/US12758606B2

## CPC

- A61K 36/74: Rubiaceae (Madder family)
- A61K 9/19: lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)}
- A61K 9/485: {Inorganic compounds}
- A61K 9/4866: {Organic macromolecular compounds}
- A61K 31/365: Lactones
- A61K 31/405: Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A61K 31/49: Cinchonan derivatives, e.g. quinine
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K 36/515: Gentiana
- A61P 3/04: Anorexiants; Antiobesity agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention describes a gastro-resistant pharmaceutical/nutraceutical composition comprising chincona cortex freeze-dried (Cinchona succirubra), chicory leaves and roots freeze-dried (Cichorium intybus, and/or Cichorium endivia, and/or Cichorium pumilum, and/or Cichorium spinosum), and gentian root freeze-dried (Gentiana lutea), and optionally griffonia seed extract (Griffonia simplicifolia). The nutraceutical composition object of the present invention is useful for appetite control, mealtime energy intake reduction, and body weight loss.

## Claims

### Claim 1

A gastro-resistant pharmaceutical or nutraceutical composition comprising:
a. cinchona cortex freeze-dried;
b. chicory leaves and roots freeze-dried; and
c. gentian root freeze-dried.

### Claim 2 (depends on 1)

The composition according to claim 1 further comprising Griffonia seeds extract.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the cinchona is Cinchona succirubra and its cortex freeze-dried contains 1-3% by weight of quinine.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the chicory is Cichorium intybus, or Cichorium endivia, or Cichorium pumilum, or Cichorium spinosum and its leaves and roots freeze-dried contains at most 350 mg/kg of lactucin.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the gentian is Gentiana lutea and its root freeze-dried contains 1-2% by weight of gentiopicrin.

### Claim 6 (depends on 2)

The composition according to claim 2, wherein the Griffonia is Griffonia simplicifolia and its seed extract contains 98% by weight of 5-HTP.

### Claim 7 (depends on 1)

The composition according to claim 1 comprising
a.
Chincona cortex freeze-dried
25-40%;
b.
Chicory leaves and roots freeze-dried
25-40%;
c.
gentian root freeze-dried
25-40%;
where the percentages indicated are expressed by weight calculated with respect to the total weight of the composition.

### Claim 8 (depends on 1)

The composition according to claim 1, wherein the components are contained in a weight ratio of 1:1:1.

### Claim 9 (depends on 1)

The composition according to claim 1, formulated as gastro-resistant capsules or tablets.

### Claim 10 (depends on 1)

A method of treatment of obesity and associated dysmetabolic diseases, said method comprising administering to a subject in need thereof a composition according to claim 1.

### Claim 11 (depends on 1)

A method of appetite control and/or mealtime energy intake reduction or body weight loss said method comprising administering to a subject in need thereof a composition according to claim 1.

### Claim 12 (depends on 7)

The composition according to claim 7, comprising
a.
Chincona cortex freeze-dried
30-35%;
b.
Chicory leaves and roots freeze-dried
30-35%;
c.
gentian root freeze-dried
30-35%;
where the percentages indicated are expressed by weight calculated with respect to the total weight of the composition.

### Claim 13 (depends on 2)

The composition according to claim 2, wherein the components are contained in a weight ratio of 1:1:1:0.15.

### Claim 14 (depends on 2)

The composition according to claim 2, comprising
a.
Chincona cortex freeze-dried
25-40%;
b.
Chicory leaves and roots freeze-dried
25-40%;
c.
gentian root freeze-dried
25-40%;
d.
griffonia seeds extract
2-15%;
where the percentages indicated are expressed by weight calculated with respect to the total weight of the composition.

### Claim 15 (depends on 12)

The composition according to claim 12, comprising
a.
Chincona cortex freeze-dried
30-35%;
b.
Chicory leaves and roots freeze-dried
30-35%;
c.
gentian root freeze-dried
30-35%;
d.
griffonia seeds extract
5-10%;
where the percentages indicated are expressed by weight calculated with respect to the total weight of the composition.
